Pre-Open Stock Movers 07/01: (CPOP) (KTRA) (FC) Higher; (CVAC) (MKSI) (ATC) Lower (more...)
Pre-Open Stock Movers:
Pop Culture Group (NASDAQ: CPOP) 89% HIGHER; yesterday's IPO adds to gains after rising 405% on debut.
Wunong Net Technology (NASDAQ: WNW) 31.8% HIGHER; sees upside trading action.
CureVac N.V. (Nasdaq: CVAC) 14.9% LOWER; announced results from the final analysis of its 40,000 subject international pivotal Phase 2b/3 study (the HERALD study) of the first-generation COVID-19 vaccine candidate, CVnCoV. In the unprecedented context of 15 strains circulating within the study population at the time of final analysis, CVnCoV demonstrated an overall vaccine efficacy of 48% (vaccine 83 vs. 145 placebo) against COVID-19 disease of any severity, including single non-respiratory mild symptoms. Significant protection was demonstrated among participants in the age group of 18 to 60, with an efficacy of 53% (vaccine 71 vs. 136 placebo) against disease of any severity and across all 15 identified strains; protection against moderate to severe disease was calculated to be 77% (9 vaccine vs. 36 placebo). In the same age group, CVnCoV provided 100% protection (vaccine 0 vs. 6 placebo) against hospitalization or death. In participants above 60 years, who represented 9% of the analysed cases, the available data did not enable a statistically significant determination of efficacy. The data confirm the favorable safety profile of CVnCoV in all age groups. The study will continue to complete follow-up analyses for trial participants. Available data have been communicated to the European Medicines Agency (EMA).
Kintara Therapeutics, Inc. (Nasdaq: KTRA) 11% HIGHER; announced topline data results from the recurrent arm of its open-label, Phase 2 clinical study of its lead compound VAL-083 being conducted at the MD Anderson Cancer Center (MD Anderson) in Houston, Texas.
Franklin Covey Co. (NYSE: FC) 6.7% HIGHER; Sales Increase to Record Third Quarter Level of $58.7 Million
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) 4% HIGHER; announced the U.S. Food and Drug Administration (FDA) approval of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) for use as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL) in pediatric and adult patients one month and older who have developed hypersensitivity to E. coli-derived asparaginase.1 Rylaze is the only recombinant erwinia asparaginase manufactured product that maintains a clinically meaningful level of asparaginase activity throughout the entire duration of treatment, and it was developed by Jazz to address the needs of patients and healthcare providers with an innovative, high-quality erwinia-derived asparaginase with reliable supply.
XPeng Inc. (NYSE: XPEV) 4.2% HIGHER; announced its vehicle delivery results for June 2021 and the second quarter 2021. XPeng recorded its highest-ever monthly deliveries in June of 6,565 Smart EVs, representing a 617% increase year-over-year, and a 15% increase over last month. The Company also achieved a quarterly record of 17,398 deliveries in the second quarter 2021, marking a 439% increase year-over-year. June deliveries consisted of 4,730 P7s, the Company’s sports smart sedan, and 1,835 G3s, its smart compact SUV. As of June 30, 2021, year-to-date total deliveries reached 30,738 units, representing a 459% increase year-over-year.
WideOpenWest (NYSE: WOW) 3.8% HIGHER; Raymond James upgraded from Market Perform to Strong Buy with a price target of $30.00.
NIO Inc. (NYSE: NIO) 3.4% HIGHER; announced its June and second quarter 2021 delivery results. NIO delivered 8,083 vehicles in June 2021, a new monthly record representing a robust 116.1% year-over-year growth. The deliveries consisted of 1,498 ES8s, the Company’s six-seater or seven-seater flagship premium smart electric SUV, 3,755 ES6s, the Company’s five-seater high-performance premium smart electric SUV, and 2,830 EC6s, the Company’s five-seater premium smart electric coupe SUV. NIO delivered 21,896 vehicles in the three months ended June 2021, a new quarterly record representing a strong increase of 111.9% year-over-year. As of June 30, 2021, cumulative deliveries of the ES8, ES6 and EC6 reached 117,597 vehicles.
Didi (NYSE: DIDI) 3.3% HIGHER; rises after gaining just 1% in its IPO debut Wednesday.
Atotech Limited (NYSE: ATC) 2.2% LOWER; MKS Instruments and Atotech Limited announced that they have entered into a definitive agreement pursuant to which MKS will acquire Atotech for $16.20 in cash and 0.0552 of a share of MKS common stock for each Atotech common share. The equity value of the transaction is $5.1 billion and the enterprise value of the transaction is approximately $6.5 billion.
DHC Acquisition (NASDAQ: DHCA) 2% HIGHER; FreeWire Technology, an EV charging a power startup, is in talks to go public through a merger with DHCA.
Micron Technology (NASDAQ: MU) 1.8% LOWER; reported Q3 EPS of $1.88, $0.17 better than the analyst estimate of $1.71. Revenue for the quarter came in at $7.42 billion versus the consensus estimate of $7.23 billion. Micron Technology sees Q4 2021 EPS of $2.20-$2.40, versus the consensus of $2.18. Micron Technology sees Q4 2021 revenue of $8-8.4 billion, versus the consensus of $7.86 billion.
ContextLogic Inc. (NASDAQ: WISH) 1.4% LOWER; announced that Chief Financial Officer Rajat Bahri has notified the Board of Directors that he plans to resign from his position effective July 23. The company has engaged executive search firm Heidrick and Struggles to identify Mr. Bahris successor.
Realty Income Corporation (NYSE: O) 1% LOWER; announced that it has commenced an underwritten public offering of 7,250,000 shares of common stock. The company also plans to grant the underwriters a 30-day option to purchase up to an additional 1,087,500 shares of common stock. The joint book-running managers for the offering are Wells Fargo Securities and Morgan Stanley.